Delivery Order SPE2DB22D3501-SPE2DB25FUZ65

Award Date 3/21/25
Potential Completion Date 3/24/25
Potential Value $3.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The firm-fixed-price delivery order, valued at $1,124.52, is for the supply of the medication LO LOESTRIN FE 1-10 TABLET 28S. The contract has a period of performance through June 11, 2024 and does not have a set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $3,746.18 for the medical product "LO LOESTRIN FE 1-10 TABLET 28S". The contract has an ultimate completion date of November 14, 2024 and a firm fixed price pricing type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,612.92 firm-fixed-price contract is for the delivery of the medication LO LOESTRIN FE 1-10 TABLET 28S, with a performance period ending on June 9, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00. This...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,318.93, is a delivery order for the pharmaceutical product LO LOESTRIN FE 1-10 TABLET 28S. The contract has an ultimate completion date of January 28, 2025 and is a firm fixed-price agreement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract award, valued at $13,069.60, is for the delivery of the medication LO LOESTRIN FE 140S. The contract has an ultimate completion date of March 24, 2025 and is a Firm Fixed Price Delivery Order with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $3,960.72, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the pharmaceutical product "LO LOESTRIN FE 1-10 TABLET 28S" with an ultimate completion date of January 22, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,020.90 firm fixed-price delivery order is for the supply of LO LOESTRIN FE 1-10 TABLET 28S, a pharmaceutical product. The contract has an ultimate completion date of October 30, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,785.01, is a firm fixed-price delivery order for the medical product "LO LOESTRIN FE 1-10 TABLET 28S". The contract has an ultimate completion date of February 14, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,756.95, is a delivery order for the supply of Lo Loestrin Fe 1-10 Tablet 28s. The contract has an ultimate completion date of January 28, 2025 and is a firm fixed-price arrangement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,756.95 delivery order contract is for the supply of 4568711234 - LO LOESTRIN FE 1-10 TABLET 28S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of July 7, 2025. This contract is not set aside and is open to all eligible vendors. AmerisourceBergen Drug...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FUZ65
    Delivery Order

This federal contract award, valued at $3,163.09, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the medical product "LO LOESTRIN FE 1-10 TABLET 28S" and has an ultimate completion date of March 24, 2025. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 6/21/25, 9:53 AM